![Nitza Thomasson-Perret](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nitza Thomasson-Perret is the founder of Brainever SAS, which was founded in 2015.
She is currently the Chairman at Ntz Consulting SASU, Director at NH TherAguix SAS, and Director at BrainTale SAS. Her former positions include Director-Preclinical Department at Sanofi, Head-Biological Studies Neurospychiatry Department at Les Laboratoires Servier SAS, Head-Early Drug Development at Fovea Pharmaceuticals SA, and Head-Preclinical Development at Gensight Biologics SA from 2013 to 2015.
She was also the Head-Development at Tissium SA.
| Sociétés | Poste | Début |
|---|---|---|
| NH THERAGUIX SAS | Directeur/Membre du Conseil | 22/02/2019 |
BrainTale SAS
 BrainTale SAS Packaged SoftwareTechnology Services Engages in the development and distribution of diagnosis and prognosis tools for brain injured patients | Directeur/Membre du Conseil | 03/06/2021 |
Ntz Consulting SASU | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
Brainever SAS
 Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Fondateur | - |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Corporate Officer/Principal | - |
| SANOFI | Corporate Officer/Principal | - |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Corporate Officer/Principal | - |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for treatment of cancer, metabolism and neurology | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 9 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for treatment of cancer, metabolism and neurology | Health Technology |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Health Technology |
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
BrainTale SAS
BrainTale SAS Packaged SoftwareTechnology Services Engages in the development and distribution of diagnosis and prognosis tools for brain injured patients | Technology Services |
Ntz Consulting SASU |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
